We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Morphosys Receives Novartis Milestone Payment for Phase 1 Trial

News   Jul 05, 2016

 
Morphosys Receives Novartis Milestone Payment for Phase 1 Trial
 
 
Advertisement
 

RELATED ARTICLES

Expert Panel Makes Weak Recommendation for Use of Remdesivir To Treat Severe COVID-19

News

International experts have made a weak recommendation for the use of remdesivir in patients with severe COVID-19, advising continuation of patient enrolment for ongoing clinical trials of remdesivir to enable the collection of additional data.

READ MORE

Test Rapidly Determines Amount of SARS-CoV-2 Neutralizing Antibodies

News

A Swiss-German team has developed a test that determines the amount of SARS-CoV-2 neutralizing antibodies within a short period of time.

READ MORE

Positive Results Reported for Phase 2 Study of Lyme Disease Vaccine Candidate

News

Positive initial results have been reported for the Phase 2 study of Lyme disease vaccine candidate VLA15.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE